Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-10-22

Clinical Trial Update: Safety and Efficacy of the Inspiromatic Inhaler in Comparison to the Aerolizer Inhaler When Delivering Formoterol [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial update evaluating the safety and efficacy of the Inspiromatic Inhaler compared with the Aerolizer Inhaler for delivering formoterol in asthma …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aerolizer Inhaler
  • Formoterol (formoterol)
  • Inspiromatic Inhaler

Snippet

Sponsor: Guy Steuer | Conditions: Asthma | Phase 1, Phase 2 | Status: UNKNOWN